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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
To determine the diagnostic accuracy of capnometry and capnography for detecting correct NGT placement in adults compared to
the reference standard.
B A C K G R O U N D
Target condition being diagnosed
The insertion of a nasogastric tube (NGT) is the passage of a
tube, appropriate for its intended purpose, via the nostril into the
stomach (National Institute for Clinical Excellence 2006). NGTs
are used within clinical practice for a variety of reasons including:
decompression, following gastric surgery, patient assessment, ad-
ministration of drugs, enteral feeding, and fluid administration.
This is an extremely common clinical intervention, with an esti-
mated one million tubes being purchased per annum in England
and Wales alone (Hanna 2010). Although the majority of these
tubes are inserted and used without incident, there is a recognised
risk that the tube can be misplaced into the lungs, or move out
of the stomach. Published reports of incidents have included oe-
sophageal, peritoneal and intestinal placement, and NGTs placed
within the brain (Burns 2001). Additionally, severe pulmonary
complications, indeed deaths, have been reported as a direct result
of NGT placement within the respiratory tract (Miller 2011). Be-
tween September 2005 andMarch 2010, 21 deaths and 79 cases of
harm relating to feeding through misplaced NGTs were reported
in the UK (National Patient Safety Agency 2011a).
Confirmation of NGT placement is required immediately follow-
ing insertion and subsequently prior to each use, for example, ad-
ministration of enteral feed or medication. Additionally, the tube
should be checked following episodes of vomiting, retching or
coughing spasms, after oropharyngeal suction has been required,
every four hours during regular feeding or where there is a sugges-
tion of tube displacement (American Association of Critical Care
Nurses 2009). Any new or unexplained respiratory symptoms or
a drop in oxygen saturation readings is a further indication for
seeking repeated confirmation of NGT placement (Durai 2009).
There are various methods used to determine NGT position, in-
cluding bedside assessment and observing for signs of respiratory
distress. Air insufflated (blown) through theNGT in combination
with epigastric ausculation (listening to the stomach with a stetho-
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scope) for whooshing sounds has also been used (Fletcher 2011).
Although these tests are widely known about, they are not officially
recommended for use as standalone measures of NGT placement.
Current guidelines from the American Association of Critical Care
Nurses 2009 and National Patient Safety Agency 2011b recom-
mend a combination of aspirate testing and radiological confirma-
tion. In a small number of patients for whom the NGT has been
placed under direct vision of an anaesthetist or surgeon, it is pos-
sible to forego chest x-ray confirmation (National Patient Safety
Agency 2011b). Observing the characteristic of fluid aspirate can
be used, with gastric secretions differing in colour and consistency
to those obtained from tracheal, bronchial or intestinal secretions
(Metheny 2001). In addition to this subjective approach, objec-
tive measures of aspirate pH can be used to assess NGT place-
ment. A pH reading of between 1 to 5.5 is considered a reliable
method for excluding placement in the pulmonary tree (National
Patient Safety Agency 2011a). The ability to obtain gastric aspirate
may not be achievable in up to 65% of patients (Hanna 2010).
Concurrently, radiography or direct visualisation are considered
the only reliable methods of confirming NGT placement (Elpern
2007; National Patient Safety Agency 2011b).
Index test(s)
The measurement of carbon dioxide (CO ) in exhaled air is a
widely used clinical observation and is a recognised standard of
care during tracheal intubation or laryngeal mask airway (Ahrens
2003; The Intensive Care Society 2009). This can be achieved
in one of two ways; capnography and colorimetric capnometry.
Capnography is the measurement of inspired and expired CO
using the absorption of infrared light by CO molecules to es-
timate CO concentrations. These measurements are then dis-
played against time to give a continual graphical trace. Detection
of a CO waveform is the test threshold for index test positivity
for capnography. Colorimetric capnometry involves the detection
of CO using an adapted form of pH filter paper, impregnated
with a dye which changes colour from purple to yellow in the
presence of CO . The colour change is the index test thresh-
old for test positivity for colorimetric capnometry. However, this
method does not provide a continual reading and can only be used
as a semi-measurement of the amount of CO in the expired gas
(Frakes 2001).
The monitoring of CO emanating from an NGT inadvertently
passed into the airways would utilise this phenomenon in a reverse
manner, confirming tracheobronchial placement rather than the
intended alimentary tract (Thomas 1998), provided that there
is circulation to deliver CO to the lungs and an absence of
complete bronchospasm preventing gas exchange (The Intensive
Care Society 2009). CO monitoring for this clinical application
has indeed been suggested, and has been a concept acknowledged
in the literature for over 20 years (Mercurio 1985).
Alternative bedside methods for detecting NGT placement have
been suggested in the literature (e.g. measurement of gastric en-
zymes byMetheny 1997 or an electromagnetic technique as evalu-
ated by Kearns 2001), however CO monitoring is the only cur-
rently available technique identified as a potential viable alterna-
tive to the reference standard appearing in clinical guidelines (The
Intensive Care Society 2009). We have therefore chosen to focus
on the detection of CO only to keep the Review manageable
and maximise clinical relevance of the comparison.
Clinical pathway
The measurement of CO in exhaled air is a recognised and
mandatory standard of care for confirming and monitoring endo-
tracheal tube or airway placement under general anaesthesia. Ad-
ditionally, it is also amandated formofmonitoring for patients un-
dergoing moderate and deep sedation (Weaver 2011). The moni-
toring of CO from anNGT has been suggested as a replacement
for the current reference standard of chest radiography.
Rationale
Several studies have examined the accuracy of colorimetric cap-
nometry in predicting gastric placement of NGTs. Very high lev-
els of specificity and sensitivity were reported against a refer-
ence standard radiograph control (Araujo-Preza 2002; Thomas
1998) or air insufflation and epigastric auscultation (Elpern 2007;
Meyer 2009). Similar results have been reported with capnog-
raphy when using a radiograph control (Kindopp 2001), and
when both capnography and colorimetric capnometry were com-
pared against both radiograph and epigastric auscultation controls
(Burns 2006).
Several narrative reviews examining various techniques for veri-
fication of NGT placement comment on the use of CO de-
tection. Some authors comment that the use of CO detection
shows promise (Ackerman 2006) with suggestions that this ap-
proach may result in cost savings (Roberts 2007). Further nar-
rative reviews conclude that radiographic confirmation remains
the most reliable method of confirming gastric NGT placement
(Bourgault 2009; Metheny 2001; Simons 2012).
Both capnography and capnometry were evaluated in a recent
meta-analysis by Chau 2011, which concluded that there was
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strong evidence available to support their use to confirmNGT po-
sition, with a sensitivity ranging from 0.88 to 1.00 and specificity
of 0.95 to 1.00. However, this work was limited both by language
and publication status and no searching of the grey literature.
A systematic review ofCO detection for testingNGTplacement
in adults is required; to identify and critically evaluate the current
evidence base and to establish the diagnostic test accuracy of this
new application of an existing clinical technology.
O B J E C T I V E S
To determine the diagnostic accuracy of capnometry and capnog-
raphy for detecting correct NGT placement in adults compared
to the reference standard.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will include studies which compare the diagnostic accuracy
of CO detection for correct NGT placement with the refer-
ence standard, and those which evaluate the diagnostic accuracy of
CO detection for differentiating between respiratory and gas-
trointestinal tube placement.Wewill include both prospective and
retrospective studies. CO detection may be assessed by either
capnometry or capnography.
Participants
Adult patients (as defined by the trialists) who are undergoing
NGT placement in any care setting for any reason. If no defini-
tion is available, we will assume the participants are adults unless
identified as children in the studies.
Index tests
The index test evaluated in this review is CO detection by either
capnometry or capnography against the reference standard.
Target conditions
We will include studies if the aim of the diagnostic test was to
confirm correct NGT placement.
Reference standards
The reference standard is either radiographic or direct visualisation
of NGT placement.
Search methods for identification of studies
Electronic searches
We will search the following databases:
1. Cochrane Register of Diagnostic Accuracy Tests (latest
issue);
2. CENTRAL (The Cochran e Library, latest issue) (Appendix
1);
3. MEDLINE (Appendix 2);
4. EMBASE (Appendix 3);
5. Medion database.
Searching other resources
We will not limit the search by language or publication status.
We will contact manufacturers of colorimetric capnometers (for
example, Easycap and Easycap II Nellcor-Puritan Bennet) and
capnographs (for example, Ohmeda 5250 RGMmonitor division
of British Oxygen Company) that have been used within trials
to identify any published, unpublished or ongoing studies which
meet the inclusion criteria.
We will review available conference proceedings from the British
Association for Parenteral and Enteral Nutrition (BAPEN), Eu-
ropean Society of Parenteral and Enteral Nutrition (ESPEN),
American Society of Parenteral and Enteral Nutrition (ASPEN),
Australian Society of Parenteral and Enteral Nutrition (AUS-
PEN), South African Society of Parenteral and Enteral Nutrition
(SASPEN) and the Latin American Federation for Parenteral and
Enteral Nutrition (FELANPE) online for relevant studies. Where
appropriate, we will contact the authors of abstracts to identify
further studies deemed worthy of review.
We will screen reference lists within relevant trials to identify any
further potential papers worthy of review.
Data collection and analysis
Selection of studies
We will undertake the systematic review using the methods out-
lined in the Cochrane Handbook for Systematic Reviews of Inter-
ventions (Higgins 2011) and the Cochrane Handbook for Reviews
of Diagnostic Interventions (Deeks 2010). Two authors (AH and
FS) will independently examine the titles and abstracts identified
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by the search strategy to remove any duplicate records and obvi-
ously irrelevant reports. We will retrieve and evaluate the full text
versions of potentially relevant studies identified by at least one
author. Two authors (AH and FS) will independently assess each
study to determine if they meet the eligibility criteria outlined
above in the section Criteria for considering studies for this review.
We will resolve any disagreements by discussion between the au-
thors (AH and FS), with a further author (KP) acting as arbiter.
We will provide details of both included and excluded studies in
the respective tables of the review.
Data extraction and management
AH and FS will extract data independently utilising a standard-
ised data extraction form (Appendix 4). We will resolve any dis-
agreements by discussion between the authors (AH and FS), with
a further author (KP) acting as arbiter. The data extraction form
will include the following:
• author, year of publication and journal/source of study;
• study design;
• total study population;
• total number of ventilated and spontaneously breathing
participants;
• total number of small and large bore feeding tubes;
• reference standard (either radiographic, direct visualisation
or endoscopic confirmation of NGT placement);
• performance of reference standard (negative or positive
confirmation of stomach placement);
• index test (either capnography or colorimetric capnometry);
• performance of index test (negative or positive confirmation
of stomach placement);
• QUADAS-2 items (i.e. the recognised quality assessment
tool for diagnostic test accuracy studies);
• data for 2 x 2 tables.
Wewill use the statistical package withinReviewManager software
(RevMan 5.2), using double data entry with two authors (AH and
FS) to control and correct data entry errors.
Assessment of methodological quality
We will assess the risk of bias of included studies using QUADAS-
2 tool for assessing risk of bias and applicability as outlined by
Whiting 2011 and recommended by the Cochrane Diagnostic
Test Accuracy Group (Wisniewski 2012). We will record this on a
study quality assessment form (Appendix 5). The qualities assessed
are described in detail in Appendix 6.
For each item in the quality assessment, a description of how the
study addressed the issue will be included and a judgement en-
tered of “low”, “high” or “unclear” for an overall risk of bias for
each domain and “low”, “high” and “unclear” overall concern for
domains one, two and three. We will include an Assessment of
methodological quality table which will detail all of the judge-
ments made for all included studies in the review. Assessment of
methodological quality will be carried out by the two authors (AH
and FS), independently .We will resolve any disagreements by dis-
cussion between the author, with a further author acting as arbiter
(KP).
Statistical analysis and data synthesis
We will extract data of diagnostic performance from each primary
study and construct 2 x 2 tables of true positive cases, false positive
cases, true negative cases and false negative cases.We anticipate that
data will be binary categorisation for all studies due to the nature
of the diagnosis under investigation (either gastric placement, or
not). Therefore, no threshold for positivity is required.
We will calculate sensitivity and specificity with a 95% confidence
interval (CI) for each study. We will present the individual study
results graphically using forest plots and the receiver operating
characteristic (ROC) space.
We will use the bivariate random-effects approach as described by
Reitsma 2005 for the meta-analysis of the pairs of sensitivity and
specificity. The bivariate approach preserves the two-dimensional
nature of the data by analysing pairs of sensitivity and specificity
jointly, incorporating any correlation that might exist between the
twomeasures using a random-effects model. Explanatory variables
may also be added to the bivariate model to investigate how these
variables affect sensitivity and specificity separately. Study level
covariates exploring the effects of mechanical ventilation, size of
tube and conscious level will be added to the analysis. We will
categorise these covariates as:
1. mechanical ventilation: ventilated or not;
2. tube size: small bore (up to 14 Fr), large bore (16 Fr and
above);
3. conscious level: impaired or not.
The bivariate mean estimates of sensitivity and specificity will
also be presented graphically along with their corresponding 95%
confidence ellipses.
We will use the Proc NLMIXED procedure available within the
statistical software package, SAS Inc., to carry out the bivariate
random-effects analyses.
Investigations of heterogeneity
Heterogeneity in test accuracy is likely to arise due to differences
in study characteristics. We will investigate this firstly using ex-
ploratory analysis and visual inspection of forest plots of sensitiv-
ities and specificities, and secondly through visual inspection of
the pairs of sensitivity and 1-specificity for each study, plotted in
’ROC space’. Study characteristics to be compared include the ’test
type’ (i.e. capnography or capnometry) and also:
1. whether the patients are mechanically ventilated or not;
2. whether the bore of the feeding tube is small (up to 14 Fr)
or large (16 Fr and above);
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3. whether the patients’ conscious level is impaired or not.
Subject to an adequate sample size of at least 10 included studies,
heterogeneity will be further investigated by adding study level
covariates to the hierarchical model to identify factors associated
with diagnostic test accuracy. The aforementioned binary categor-
ical covariates will be considered for inclusion in the model.
Sensitivity analyses
We will use sensitivity analysis to restrict studies with an appropri-
ate spectrumof patients, superior form of index test (capnography)
and reference test (chest x-ray or direct visualisation) and studies
at low risk of verification bias (i.e. with predetermined criteria for
chest x-ray interpretation). These covariates will be incorporated
in the bivariate model to examine the effect of potential sources
of bias across subgroups of studies.
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A P P E N D I C E S
Appendix 1. CENTRAL search strategy
1. Intubation, Gastrointestinal/
2. Enteral Nutrition/
3. ((nasal or nose or nasoenteral or nasogastric) adj2 (cannula or tube or intubation)).tw.
4. Feeding tube.tw.
5. Ryles tube.tw.
6. Fine bore tube.tw.
7. or/1-6
8. capnography/
9. (capnography or capnogram).tw.
10. capnometry.tw.
11. (carbon dioxide adj (detect* or monitor*)).tw.
12. or/8-11
13. 7 and 12
Appendix 2. MEDLINE search strategy
1. Intubation, Gastrointestinal/
2. Enteral Nutrition/
3. ((nasal or nose or nasoenteral or nasogastric) adj2 (cannula or tube or intubation)).tw.
4. Feeding tube.tw.
5. Ryles tube.tw.
6. Fine bore tube.tw.
7. or/1-6
8. capnography/
9. (capnography or capnogram).tw.
10. capnometry.tw.
11. (carbon dioxide adj (detect* or monitor*)).tw.
12. or/8-11
13. 7 and 12
Appendix 3. EMBASE search strategy
1. nasogastric tube/
2. ((nasal or nose or nasoenteral or nasogastric) adj2 (cannula or tube and intubation)).tw.
3. fine bore tube.tw.
4. enteric feeding/
5. feeding apparatus/
6. feeding tube.tw.
7. Ryles tube.tw.
8. or/1-7
9. capnography/
10. (capnography or capnogram).tw.
11. capnometry.tw.
12. (carbon dioxide adj (detect* or monitor*)).tw.
13. or/9-12
14. 8 and 13
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Appendix 4. Data extraction form
Source
Study ID Report ID Review author name
First author Full reference
Study eligibility
Type of study
Does the study compare:
- CO2 against ref.
standard∗ for respiratory
NGT placement
OR
- CO2 against ref. stan-
dard for respiratory/gas-
tric NGT placement
Yes Unclear No
Next question Next question Exclude
Participants
Were the participants
having naso gastric tube
placement?
Yes Unclear No
Next question Next question Exclude
Were the participants:
- defined as adult by
trialists
OR
- not identified as pae-
diatric
Yes Unclear No
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(Continued)
Next question Next question Exclude
Index tests
Did the study evalu-
ate CO2 detection by
capnometry against ref.
standard?
Yes Unclear No
Next question Next question Next question
Did the study evalu-
ate CO2 detection by
capnography against ref.
standard?
Yes Unclear No
Next question Next question Exclude
Target conditions
Was the aim of the di-
agnostic test to confirm
NGT placement?
Yes Unclear No
Next question Next question Exclude
Outcomes
Did the study record+
performance of reference
standard?
Yes Unclear No
Next question Next question Next question
Did the study record
performance of index
test?
Yes Unclear No
Include
Include
(subject to clarification of “unclear”
points)
Exclude
Final decision Include Unclear Exclude
* reference standard is either radiographic, direct visualisation or endoscopic confirmation of NGT placement
+ remember we are looking for recording of outcomes, not reporting
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If the study is to be excluded, record the reason and details to add to “Table of excluded studies”:
General information
Authors
Contact address
Country of study
Language of publication
Any other published versions/reports of this trial?
All references to a trial need to be linked under one Study ID both on this form (p1) and in RevMan.
Code Authors Full reference Linked Study ID on p1?
(tick)
Linked Study ID in RevMan?
(tick)
A
B
C
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(Continued)
Add other additional lines/codes as required
Participants
Age (mean, median, range)
Sex (numbers/%)
Trial characteristics
Study design
Single/multicentre?
Country/countries
Definition used of participant eligibility
Total study population
Total number of ventilated patients
Total number of spontaneously breathing
patients
Total number of small bore feeding tubes
Total number of large bore feeding tubes
Aim of diagnostic test
(e.g. NGT placement in stomach or exclu-
sion of respiratory placement)
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(Continued)
Reference standard used
(either radiographic, direct visualisation or
endoscopic confirmation)
Detail reference standard process
(if available)
Index test
(either capnography or colorimetric cap-
nometry)
Detail index test process
Include:
- Time between reference test and index
test
- CO2 detector details (make, model)
Comparison: capnometry and capnography
for detecting correct NGT placement in
adults compared to the reference standard
Test outcome (CO2 detection)
NGT placement (reference standard result)
Totals
Gastric
Not
Gastric
Not
Totals:
Comparison: capnometry and capnography
for detecting respiratory tube placement
Test outcome (CO2 detection)
NGT Placement(reference standard result)
Totals
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(Continued)
Respiratory
Gastric
Respiratory
Gastric
Totals:
Comparison: capnometry and capnography
for detecting correct gastric tube placement
Test outcome (CO2 detection)
NGT placement (reference standard result)
Totals
Respiratory
Gastric
Respiratory
Gastric
Totals:
Any additional information:
Appendix 5. Study quality assessment form
Trial characteristics - QUADAS-2 items
Phase 1: State the review question
Patients (setting, intended use of index test, presentation, prior testing):
Index test (s):
Reference standard and target condition:
Phase 2: Draw a flow diagram for the primary study
Phase 3: Risk of bias and applicability judgements
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Domain 1: Patient selection
A. Risk of bias
Described methods of patient selection:
Was a consecutive or random sample of patients enrolled? Yes/No/Unclear
Was a case-control design avoided? Yes/No/Unclear
Did the study avoid inappropriate exclusions?
- Did the study avoid excluding difficult to pass NGT patients?
Yes/No/Unclear
Could the selection of patients have introduced bias? Risk: LOW/HIGH/UNCLEAR
B. Concerns regarding applicability
Describe included patients (prior testing, presentation, intended use of index test and setting):
Is there concern that the included patients do not match the
review question?
Risk: LOW/HIGH/UNCLEAR
Domain 2: Index test (capnometry/capnography)
A. Risk of bias
Describe the index test and how it was conducted and interpreted:
Were the index test results interpreted without knowledge of the
results of the reference standard?
Yes/No/Unclear
If a threshold was used, was it pre-specified? Yes/No/Unclear
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(Continued)
Could the conduct or interpretation of the index test have
introduced bias?
Risk: LOW/HIGH/UNCLEAR
B. Concerns regarding applicability
Is there concern that the index test, its conduct, or interpre-
tation differ from the review question?
Risk: LOW/HIGH/UNCLEAR
Domain 3: Reference standard (chest x-ray/direct visualisation)
A. Risk of bias
Describe the reference standard and how it was conducted and interpreted:
Is the reference standard likely to correctly classify the target con-
dition?
- Were currently acceptable methods for determining NGT
placement used?
Yes/No/Unclear
Were the reference standard results interpretedwithout knowledge
of the results of the index test?
Yes/No/Unclear
Could the conduct or interpretation of the reference standard
have introduced bias?
Risk: LOW/HIGH/UNCLEAR
B. Concerns regarding applicability
Is there concern that the target condition as defined by the
reference does not match the review question?
- Consider the use of chest x-ray interpretation criteria, or
physician judgement alone
Risk: LOW/HIGH/UNCLEAR
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Domain 4: Flow and timing
A. Risk of bias
Describe any patient who did not receive the index test(s) and/or reference standard or who were excluded from the 2x2 table (refer
to flow diagram):
Describe the time interval and any intervention between index tests and reference standard:
Was there an appropriate interval between index tests and refer-
ence standard?
- We have set arbitrary 4 hours for this review
Yes/No/Unclear
Did all patients receive the reference standard? Yes/No/Unclear
Did patient receive the same reference standard?
Were all patients included in the analysis?
- Consider withdrawals and withdrawals who were likely to
impact on study results
- Also consider the exclusion of “difficult” patients
Could the patient flow have introduced bias? Risk: LOW/HIGH/UNCLEAR
Appendix 6. Study quality assessment details
• Domain 1: Patient selection
Risk of bias: Could the selection of patients introduced bias?
Signalling question 1: Was a consecutive or random sample of patients enrolled?
Signalling question 2: Was a case-control design avoided?
Signalling question 3: Did the study avoid inappropriate exclusions?
Certain conditions may make the passage of an NGT more difficult, such as anatomical variation of the larynx and pharynx and
altered physiology of swallowing (Der Kureghian 2011). We will classify studies where patients who are difficult to pass an NGT in
are excluded as “yes”, those who did not as “no” and “unclear” where this information is unclear.
Applicability: Are there concerns that the included patients and the setting do not match the review question?
The inclusion criteria for this review outlines studies for inclusion in which the patients are considered to require an NGT passed for
any reason. Therefore, we anticipate that all the studies in the review will be judged as “low” concern.
• Domain 2: Index test
Risk of bias: Could the conduct or interpretation of the index test have introduced bias?
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Signalling question 1: Were the index test results interpreted without knowledge of the results of the reference standard?
Signalling question 2: If a threshold was used, was it pre-specified?
We will classify the study as “yes” if the index test results were interpreted without knowledge of the reference standard, “no” if the
index tests were interpreted with knowledge of the reference standard results and “unclear” if this information is not clear.
Applicability: Are there concerns that the index test, its conduct or interpretation differ from the review question?
The detection of carbon dioxode by capnometry or capnography for determining NGT placement is an inclusion criteria for this
review, so we anticipate that all studies will be classified as “low” concern.
• Domain 3: Reference standard
Risk of bias: Could the reference standard, its conduct or its interpretation have introduced bias?
Signalling question 1: Is the reference standard likely to correctly classify the target condition?
Signaling question 2: Were the reference standard results interpreted without knowledge of the results of the index test?
We will classify the studies as “yes” if the criteria for correct NGT placement were the currently acceptable standards of placement
verification (outlined in Reference standards), “no” if the criteria for verification of placement were by any other method and “unclear”
if this information is not clear.
We will classify the study as “yes” if the reference test results were interpreted without knowledge of the index test, “no” if the reference
standard was interpreted with knowledge of the index test results and “unclear” if this information is not clear.
Applicability: Are there concerns that the target condition as defined by the reference standard does not match the question?
The target condition is the confirmation of NGT placement in the stomach, which may be improved by the use of pre-specified
diagnostic criteria for chest x-ray interpretation (Lamont 2011). The threshold at which an x-ray is interpreted as positive (i.e. NGT in
the stomach) may, therefore, be different dependent on whether the interpretation was based on individual clinician’s interpretation or
according to clear diagnostic criteria. We will classify those studies which used clear diagnostic criteria for chest x-ray interpretation as
“low” concern, for those who did not or where the interpretation was based on individual clinician’s interpretation as “high” concern,
and “unclear” concern if this information is not clear.
• Domain 4: Flow and timing
Risk of bias: Could the patient flow have introduced bias?
Signalling question 1: Was there an appropriate interval between the index test and reference standard?
Signalling question 2: Did all patients receive the same reference standard?
Signalling question 3: Were all patients included in the analysis?
If an NGT is correctly inserted and initial gastric placement is confirmed, continual assessment is still required as any routine activity
(e.g. vomiting, coughing, retching) can cause tube displacement (Simons 2012). Therefore, any delay in testing may influence results.
However, we have set an arbitrary time delay between tests in line with the American Association of Critical Care Nurses 2009 who
recommend tube location to be checked at four hourly intervals. We will classify the study as “yes” if the delay is less than four hours,
“no” if the delay is four hours or more and “unclear if the information is unclear.
We will classify the study as ”yes“ if all patients had the same reference standard, ”no“ if the reference standard was different and
”unclear“ if this information is unclear.
Uninterpretable results may be present (e.g. unclear chest x-ray, blocked NGT preventing gas flow required for capnography/capnome-
try). Additionally, withdrawals from the study may be present. We will classify the study as ”yes“ if uninterpretable results were reported
and the study had no withdrawals or the withdrawals were unlikely to affect the results, ”no“ if uninterpretable results were not reported
or there were withdrawals that were likely to affect the results, or both, and ”unclear“ if this information is not clear.
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